Chargement en cours...
BEZ235: When Promising Science Meets Clinical Reality
An article in a recent issue of The Oncologist reports the results of a phase I clinical trial of BEZ235 in patients with advanced renal cell carcinoma. The study was terminated early due to toxicity and a lack of clinical efficacy. The rapid and concise publication of this type of clinical result i...
Enregistré dans:
| Publié dans: | Oncologist |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
AlphaMed Press
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5016067/ https://ncbi.nlm.nih.gov/pubmed/27566248 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0243 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|